Sang Hoon Paik PhD

Sang Hoon Paik had worked in pharmaceutical company research institute for more than 22 years, currently he is a General Manager of Cell Therapy Research Center in Green Cross LabCell (GCLC) Corp. He got a Ph.D. degree in Biotechnology, and developed therapeutic biologics by cell culture technology against blood borne diseases and genetic disorder.

Based on long term experience of cell culture biotechnology, he started to develop in NK cell therapy for cancer treatment. By developing NK cell therapeutics, his research area extends from process development to commercial scale production using bioreactor. He has conducted the world first clinical trial using random donor derived expanded NK cell and few more clinical trials in hepatocellular carcinoma, acute leukemia and neuroblastoma with or without lymphodepletion. Currently this NK cell program goes on phase IIa against HCC.